Skip to main content

Table 1 (abstract A65). Correlations with depression (PHQ9) and anxiety (GAD7) scores in youth with SLE

From: Proceedings of the 2019 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Annual Scientific Meeting

  PHQ9 score GAD7 score
GAD7 score 0.7, p<0.0001 1.00
SLEDAI score 0.07, p=0.6 0.2, p=0.2
Steroid dose -0.05, p=0.7 -0.1, p=0.3
Disease duration 0.06, p=0.6 0.02, p=0.9
PROMIS measures:
 Worse depression 0.7, p<0.0001 0.7, p<0.0001
 Worse anxiety 0.6, p<0.0001 0.8, p<0.0001
 Worse fatigue 0.7, p<0.0001 0.6, p<0.0001
 Stronger peer relationships -0.3, p=0.002 -0.4, p=0.009
 Lower physical functioning 0.4, p=0.0001 0.4, p=0.0004
 Higher pain interference 0.5, p<0.0001 0.6, p<0.0001
 Higher pain severity 0.5, p<0.0001 0.4, p=0.0003
  1. PHQ9 (Patient Health Questionnaire-9) scores ranged from 0-27; GAD7 (Generalized Anxiety 7-Index) scores ranged from 0-21. SLEDAI (SLE Disease Activity Index 2K Modification) scores ranged from 0-20 (of a possible range 0-105). Steroid dose was current daily dose. PROMIS (Patient Reported Outcome Measurement Information System) scores were measured as T-scores, except for pain severity measured on a scale of 1-10. Spearman rho correlation coefficients shown